Bookmark list

Phenomenex to be Acquired by Danaher Corporation

12-Oct-2016 - USA

Phenomenex Inc. announced it has signed a definitive agreement to be acquired by Danaher Corporation. Phenomenex will operate as a standalone operating company, retaining the Phenomenex brand, its personnel and site locations.

"Phenomenex is a widely recognizable brand that we are proud to say is highly respected and well established as providing high-quality consumables to the scientific community worldwide," said Fasha Mahjoor, CEO, Phenomenex. "Joining Danaher will allow us to maintain the high pace of innovation that our customers and international distributors have come to expect from us. This is our opportunity to further expand our R&D activities, benefit our customers with a more diversified product portfolio and reinforce our market leadership."

"We are thrilled to have Phenomenex join Danaher's life sciences portfolio of businesses, which include SCIEX, Beckman Coulter Life Sciences, Pall, Leica Microsystems and Molecular Devices," said Dan Daniel, Executive Vice President, Danaher. "Phenomenex is a strong business characterized by high growth rates and margins and excellent growth prospects driven by increasing analytical testing needs in the health, research and environmental segments. The Danaher Business System (DBS) has a strong track record of helping businesses rapidly scale operations and create long-term customer value. We look forward to supporting the Phenomenex team in leveraging DBS tools for growth and welcoming them to our Life Sciences team."

The transaction, which is expected to close by late 2016, is subject to customary closing conditions and regulatory approvals.

https://www.bionity.com/en/news/160179/phenomenex-to-be-acquired-by-danaher-corporation.html

Bayer Acquires German Biotech Start-up Targenomix

Targenomix will contribute to Bayer’s Crop Science R&D pipeline by continuing to deliver novel systems biology approaches for innovative crop protection discovery

Get the life science industry in your inbox

Phenomenex to be Acquired by Danaher Corporation

Bayer Acquires German Biotech Start-up Targenomix

Other news from the department business & finance

Infrareal takes over pharmaceutical and biotech site in Orth, Lower Austria from Takeda

KNAUER now officially a place of the future

Better standard for laboratory analysis

Medtech start-up is developing a novel obesity therapy

Side-effect free RNA therapeutics active only in diseased cells

Merck accelerates growth, driven by all business sectors

Mainz Biomed and Thermo Fisher Scientific sign collaboration agreement

mediaire transforms radiology with AI

Click & Try: A Failed Experiment and Chance Opened up new Paths to an Established Reaction for Chemists

Turning waste into microbial gold for a sustainable future

Bayer: Strategic progress in challenging business environment

Collaboration between medac and start-up chiron to develop organ-on-chip technology

Cyber Valley unites AI & robotics expertise for the healthcare sector

What influences the success of founders

BASF partners with Acies Bio to drive sustainable production of Personal and Home Care ingredients

Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany

Evotec announces sale of API manufacturing facility to Monacum Partners

Aignostics secures $34 million Series B to improve precision medicine with AI

Successful closing: Syntegon and Telstar officially join forces

Berlin-Based Neurotech Startup Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease

Get the life science industry in your inbox

Most read news

Berlin-Based Neurotech Startup Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease

Microbe of the Year 2023: Bacillus subtilis – for health and technology

Superspreader fibrils caught in the act

The preparation makes the poison

A “chemical ChatGPT” for new medications

Protein interactions: who is partying with whom and who is ruining the party?

Possible approach for the treatment of neurological and neuropsychiatric diseases discovered

Is the physics of red blood cells in bats a key to "artificial hibernation" for humans?

Understanding How Mutations Affect Diseases

Ovulation filmed from start to finish for the first time

Diabetes switch in DNA

Bayer partners with innovative hormone monitoring device start-up

More news from our other portals

Flower Power: Lavender Oil Fuels Batteries for the Future

Energy drinks - the underestimated danger

AI-driven mobile robots team up to tackle chemical synthesis

The fireproof battery

Precise and fast kokumi effect

Researcher finds gold - and other metals

Hydrogen: Breakthrough in alkaline membrane electrolyzers

Solein® tops the list of NASA’s alternatives for space food systems

Machine learning can predict the mechanical properties of polymers

When it comes to building muscle, not all proteins are created equal

Hazardous chemicals found in cosmetics

Mintel announces Global Food and Drink Trends for 2025

New technology for solid state batteries

1.3 million pizzas with solar power

Inspired by nature: biophysicist develops innovative microplastic filters

Full-bodied cheese flavor–prediction of flavor development soon possible thanks to new method

New Fast and Sustainable Method for Hydrogen Production

With “electro-agriculture,” plants can produce food in the dark and with 94% less land, bioengineers say

Porsche may acquire stake in Varta and majority stake in e-mobility division "V4Drive"

Sustainable food innovations from broccoli side streams

Life of zinc batteries drastically extended

Making scents of aromas that differentiate beer and wine

All FT-IR spectrometer manufacturers at a glance